Diabetes 50:150-158, 2001
© 2001 by the American Diabetes Association, Inc.
Oral Glucose Tolerance Test Minimal Model Indexes of ß-Cell Function and Insulin Sensitivity
Elena Breda,
Melissa K. Cavaghan,
Gianna Toffolo,
Kenneth S. Polonsky, and
Claudio Cobelli
From the Department of Electronics and Informatics (E.B., G.T., C.C.),
University of Padova, Padova, Italy; the Department of Medicine (M.K.C.), The
University of Chicago, Chicago, Illinois; and the Department of Medicine
(K.S.P.), Washington University School of Medicine, St. Louis, Missouri.
Address correspondence and reprint requests to Claudio Cobelli, Dipartimento
di Elettronica e Informatica, Via Gradenigo 6a, 35131 Padova, Italy. E-mail:
cobelli{at}dei.unipd.it
.
The simultaneous assessment of quantitative indexes of insulin secretion
and action in a single individual is important when quantifying their relative
role in the evolution of glucose tolerance in different physiopathological
states. Available methods quantify these indexes in relatively
nonphysiological conditions, e.g., during glucose clamps or intravenous
glucose tolerance tests. Here, we present a method based on a physiological
test applicable to large-scale genetic and epidemiologic studiesthe
oral glucose tolerance test (OGTT). Plasma C-peptide, insulin, and glucose
data from a frequently sampled OGTT with 22 samples throughout 300 min
(FSOGTT300-22) were analyzed in 11 subjects with various degrees of
glucose tolerance. In each individual, two indexes of pancreatic sensitivity
to glucose ( s [109 min-1] and
d [109]) and the insulin sensitivity index
(SI) (105 dl/kg per min per pmol/l) were
estimated by using the minimal model of C-peptide secretion and kinetics
originally proposed for intravenous graded glucose infusion and the minimal
model approach recently proposed for meal/OGTTs. The indexes obtained from
FSOGTT300-22 were used as a reference for internal validation of
OGTT protocols with reduced sampling schedules. Our results show that 11
samples in a 300-min period (OGTT300-11) is the test of choice
because the indexes it provides ( s = 36 ± 3 [means
± SE]; d = 710 ± 111; SI =
10.2 ± 2.4) show excellent correlation and are not statistically
different from those of FSOGTT300-22 ( s = 33
± 3; d = 715 ± 120; SI =
10.1 ± 2.3). In conclusion, OGTT300-11, interpreted with
C-peptide and glucose minimal models, provides a quantitative description of
ß-cell function and insulin sensitivity in a single individual while
preserving the important clinical classification of glucose tolerance provided
by the standard 120-min OGTT.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. M. Jauslin, H. E. Silber, N. Frey, R. Gieschke, U. S. H. Simonsson, K. Jorga, and M. O. Karlsson
An Integrated Glucose-Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics
J. Clin. Pharmacol.,
October 1, 2007;
47(10):
1244 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cobelli, G. M. Toffolo, C. D. Man, M. Campioni, P. Denti, A. Caumo, P. Butler, and R. Rizza
Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests
Am J Physiol Endocrinol Metab,
July 1, 2007;
293(1):
E1 - E15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bertuzzi, S. Salinari, and G. Mingrone
Insulin granule trafficking in beta-cells: mathematical model of glucose-induced insulin secretion
Am J Physiol Endocrinol Metab,
July 1, 2007;
293(1):
E396 - E409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza
Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes
Diabetes,
April 1, 2007;
56(4):
1113 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Campioni, G. Toffolo, L. T. Shuster, F. J. Service, R. A. Rizza, and C. Cobelli
Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E54 - E60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Cohen, R. Basu, G. Bock, C. Dalla Man, M. Campioni, A. Basu, G. Toffolo, C. Cobelli, and R. A. Rizza
Prediction of Postprandial Glycemic Exposure: Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength
Diabetes Care,
December 1, 2006;
29(12):
2708 - 2713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Steil, K. Rebrin, C. Darwin, F. Hariri, and M. F. Saad
Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
Diabetes,
December 1, 2006;
55(12):
3344 - 3350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza
Pathogenesis of Pre-Diabetes: Mechanisms of Fasting and Postprandial Hyperglycemia in People With Impaired Fasting Glucose and/or Impaired Glucose Tolerance
Diabetes,
December 1, 2006;
55(12):
3536 - 3549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Petersen, S. Dufour, J. Feng, D. Befroy, J. Dziura, C. D. Man, C. Cobelli, and G. I. Shulman
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
PNAS,
November 28, 2006;
103(48):
18273 - 18277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Panteleon, M. Loutseiko, G. M. Steil, and K. Rebrin
Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system.
Diabetes,
July 1, 2006;
55(7):
1995 - 2000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, C. Dalla Man, M. Campioni, A. Basu, G. Klee, G. Toffolo, C. Cobelli, and R. A. Rizza
Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction.
Diabetes,
July 1, 2006;
55(7):
2001 - 2014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dalla Man, K. E. Yarasheski, A. Caumo, H. Robertson, G. Toffolo, K. S. Polonsky, and C. Cobelli
Insulin sensitivity by oral glucose minimal models: validation against clamp
Am J Physiol Endocrinol Metab,
December 1, 2005;
289(6):
E954 - E959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dalla Man, M. Campioni, K. S. Polonsky, R. Basu, R. A. Rizza, G. Toffolo, and C. Cobelli
Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol: Minimal Model Assessment of {beta}-Cell Responsivity and Insulin Sensitivity in Nondiabetic Individuals
Diabetes,
November 1, 2005;
54(11):
3265 - 3273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Man, A. Caumo, R. Basu, R. Rizza, G. Toffolo, and C. Cobelli
Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model
Am J Physiol Endocrinol Metab,
November 1, 2005;
289(5):
E909 - E914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Camastra, M. Manco, A. Mari, S. Baldi, A. Gastaldelli, A. V. Greco, G. Mingrone, and E. Ferrannini
{beta}-Cell Function in Morbidly Obese Subjects During Free Living: Long-Term Effects of Weight Loss
Diabetes,
August 1, 2005;
54(8):
2382 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Nielsen, A. Caumo, N. K. Aagaard, V. Chandramouli, W. C. Schumann, B. R. Landau, O. Schmitz, and H. Vilstrup
Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations
Am J Physiol Gastrointest Liver Physiol,
June 1, 2005;
288(6):
G1135 - G1143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ciampelli, F. Leoni, F. Cucinelli, S. Mancuso, S. Panunzi, A. De Gaetano, and A. Lanzone
Assessment of Insulin Sensitivity from Measurements in the Fasting State and during an Oral Glucose Tolerance Test in Polycystic Ovary Syndrome and Menopausal Patients
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1398 - 1406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ferrannini, S. Camastra, A. Gastaldelli, A. Maria Sironi, A. Natali, E. Muscelli, G. Mingrone, and A. Mari
Beta-Cell Function in Obesity: Effects of Weight Loss
Diabetes,
December 1, 2004;
53(suppl_3):
S26 - S33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E371 - E385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Steil, C.-m. Hwu, R. Janowski, F. Hariri, S. Jinagouda, C. Darwin, S. Tadros, K. Rebrin, and M. F. Saad
Evaluation of Insulin Sensitivity and {beta}-Cell Function Indexes Obtained From Minimal Model Analysis of a Meal Tolerance Test
Diabetes,
May 1, 2004;
53(5):
1201 - 1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al.
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001
Diabetes,
January 1, 2004;
53(1):
250 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Piatti, C. Di Mario, L. D. Monti, G. Fragasso, F. Sgura, A. Caumo, E. Setola, P. Lucotti, E. Galluccio, C. Ronchi, et al.
Association of Insulin Resistance, Hyperleptinemia, and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting
Circulation,
October 28, 2003;
108(17):
2074 - 2081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, E. Breda, A. L. Oberg, C. C. Powell, C. Dalla Man, A. Basu, J. L. Vittone, G. G. Klee, P. Arora, M. D. Jensen, et al.
Mechanisms of the Age-Associated Deterioration in Glucose Tolerance: Contribution of Alterations in Insulin Secretion, Action, and Clearance
Diabetes,
July 1, 2003;
52(7):
1738 - 1748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Larsen, B. Rolin, M. Wilken, R. D. Carr, and C. F. Gotfredsen
Measurements of Insulin Secretory Capacity and Glucose Tolerance to Predict Pancreatic {beta}-Cell Mass In Vivo in the Nicotinamide/Streptozotocin Gottingen Minipig, a Model of Moderate Insulin Deficiency and Diabetes
Diabetes,
January 1, 2003;
52(1):
118 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mari, O. Schmitz, A. Gastaldelli, T. Oestergaard, B. Nyholm, and E. Ferrannini
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects
Am J Physiol Endocrinol Metab,
December 1, 2002;
283(6):
E1159 - E1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mari, A. Tura, A. Gastaldelli, and E. Ferrannini
Assessing Insulin Secretion by Modeling in Multiple-Meal Tests: Role of Potentiation
Diabetes,
February 1, 2002;
51(90001):
S221 - 226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Breda, G. Toffolo, K. S. Polonsky, and C. Cobelli
Insulin Release in Impaired Glucose Tolerance: Oral Minimal Model Predicts Normal Sensitivity to Glucose but Defective Response Times
Diabetes,
February 1, 2002;
51(90001):
S227 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|